Skip to content

Gyre Therapeutics, Inc. GYRE All Other Segments — Transaction Costs

Other segment segments

Gyre
$2.55M
Gyre Pharmaceuticals
$0

Similar metrics at other companies

Liberty Energy logo
LBRTTransaction and other costs
$0-100%
YSS
YSSReportable Segment — Transaction costs
$5.93M+19,013%
PAR Technology logo
PARReportable Segment — Transaction costs
$594K-48.6%
ePlus logo
PLUSAll Other Segments — Total Costs & Expenses
$43K-39.4%
Skyward Specialty Insurance Group, Inc. logo
SKWDReportable Segment — Transaction costs
$3.5M
KKR & Co. logo
KKRAsset Management and Insurance Segments — Transaction-related costs and other corporate actions
$30M

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept gyre:TransactionCosts.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s all other segments — transaction costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s all other segments — transaction costs?
Gyre Therapeutics, Inc. (GYRE) reported all other segments — transaction costs of $0 in Q1 2026.
What does all other segments — transaction costs mean?
This metric tracks the specific costs incurred during business transactions, such as mergers, acquisitions, or divestitures, related to the 'All Other Segments' business unit. These costs are typically non-recurring and reflect the financial impact of corporate restructuring or strategic changes within this segment. Monitoring these costs helps investors isolate the impact of one-time events from ongoing operational performance.